Ghana vs Sierra Leone: Contraceptive prevalence, any modern method
Contraceptive prevalence, any modern method over time
- Ghana
- Sierra Leone
How they compare
Sierra Leone currently reports 23.9% against 23.4% in Ghana, a difference of 0.5%.
The two have swapped places 1 time across 5 shared years of data; in 1992 it was Ghana ahead.
Ghana ranks 46th and Sierra Leone ranks 44th of 62 countries.
Across the 3 decades both report, Ghana averaged higher in 2 and Sierra Leone in 1.
Head to head by decade
| Decade | Ghana | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 7.2% | 2.4% | 4.8% | Ghana |
| 2000s | 12.6% | 7.7% | 4.8% | Ghana |
| 2010s | 17.6% | 23.4% | 5.8% | Sierra Leone |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher contraceptive prevalence, any modern method, Ghana or Sierra Leone?
- Sierra Leone, at 23.9% against 23.4% in Ghana as of 2019.
- What is the difference in contraceptive prevalence, any modern method between Ghana and Sierra Leone?
- 0.5%, with Sierra Leone ahead.
- How many years of comparable data are there for Ghana and Sierra Leone?
- 5 years are reported by both, from 1992 to 2017.
- How do Ghana and Sierra Leone rank globally for contraceptive prevalence, any modern method?
- Ghana ranks 46th and Sierra Leone ranks 44th of 62 countries.
- Where does this data come from?
- Household surveys, including Demographic and Health Surveys and Multiple Indicator Cluster Surveys. Largely compiled by United Nations Population Division, published as Contraceptive prevalence, any modern method (% of all women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Contraceptive prevalence, any modern method is the percentage of all women ages 15-49 who are practicing, or whose sexual partners are practicing, at least one modern method of contraception. Modern methods of contraception include female and male sterilization, oral hormonal pills, the intra-uterine device (IUD), the male condom, injectables, the implant (including Norplant), vaginal barrier methods, the female condom and emergency contraception.